Literature DB >> 25434453

[A case of mFOLFOX6-induced lactic acidosis in a patient with colon cancer].

Atene Ito1, Kazuyuki Kawamoto, Taebun Park, Tadashi Ito.   

Abstract

Leucovorin calcium, 5-fluorouracil, and oxaliplatin (FOLFOX) therapy is a standard chemotherapy regimen used to treat colorectal cancer. Peripheral nerve disorder and myelosuppression are frequently reported treatment-related adverse events. With modified FOLFOX6 (mFOLFOX6) therapy, adverse events of an altered mental state with reversible posterior leukoencephalopathy and hypoammonemia have been reported, while lactic acidosis is uncommon. We describe a case of mFOLFOX6 - induced lactic acidosis in a 64-year-old man with colorectal cancer who underwent pelvic exenteration following chemotherapy. Postoperative histopathological analysis revealed residual cancer. Following the commencement of mFOLFOX6 therapy, the patient experienced emesis, hiccupping, and an altered mental state. Laboratory testing revealed only severe lactic acidosis, while diagnostic imaging was unrevealing. All symptoms quickly improved upon the administration of intravenous infusion of sodium bicarbonate.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25434453

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  2 in total

1.  Type B lactic acidosis from fluorouracil in fluorouracil, oxaliplatin and leucovorin treatment for carcinoma of the colon in a hemodialysis patient.

Authors:  Emily K Yeung; Michael A Copland; Sharlene Gill
Journal:  Clin Kidney J       Date:  2018-03-12

2.  A Rare Case of Severe Lactic Acidosis from 5-Fluorouracil after mFOLFOX6 Treatment in a Patient with Advanced Gastric Cancer.

Authors:  Tae Hoon Lee; Dan Le
Journal:  Case Rep Oncol       Date:  2021-03-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.